Granules India gains key FDA approval for Unit V facility, marking major compliance milestone
Hyderabad-based Granules India Limited has achieved a significant regulatory milestone, securing an Establishment Inspection Report (EIR) with a “No Action Indicated” (NAI) status from the ... Read More
Granules India faces six observations after US FDA inspection at Gagillapur facility in Hyderabad
Granules India Limited has recently completed a US Food and Drug Administration (US FDA) inspection at its Gagillapur facility in Hyderabad, Telangana, resulting in six ... Read More